Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-03-05 @ 3:31 AM
Study NCT ID:
NCT05231369
Status:
UNKNOWN
Last Update Posted:
2023-02-10
First Post:
2022-02-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Immunogenicity of ChulaCov19 BNA159 mRNA Vaccine
Sponsor:
Chulalongkorn University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | View |
| None | Tolerability of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | View |
| None | Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | View |
| None | Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | View |
| None | Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | View |
| None | Immune Response of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | View |
| None | Assess Which Dose is Appropriate to Use | View |
Keywords: